Delayed Onset of COVID-19 in an Immunosuppressed Patient

Kaitlin Liroff1, Christine Fleury1, Cristian Dumitrescu1

  • 1Division of Infectious Disease and Travel Medicine, MedStar Health Georgetown, University Hospital, Washington, DC.

Insights

This case study discusses a postpartum patient with delayed COVID-19 symptoms, complicated by cytomegalovirus viremia. High suspicion for coronavirus disease 2019 is crucial, even with late symptom onset, due to treatment and public health factors.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Virology

Background:

  • Postpartum immunosuppression can alter typical disease presentations.
  • Cytomegalovirus (CMV) viremia is a potential confounding factor in diagnosing infections.
  • Delayed presentation of infectious diseases poses diagnostic challenges.

Observation:

  • A postpartum patient presented with delayed symptoms of coronavirus disease 2019 (COVID-19).
  • The patient was also diagnosed with cytomegalovirus (CMV) viremia, complicating the clinical picture.
  • The interplay between immunosuppression, CMV, and COVID-19 required careful evaluation.

Findings:

  • Despite delayed onset, COVID-19 was confirmed in the patient.
  • The presence of CMV viremia did not preclude a concurrent COVID-19 diagnosis.
  • This case underscores the variability in COVID-19 symptom manifestation.

Implications:

  • Maintaining a high index of suspicion for COVID-19 is vital, irrespective of symptom onset timing.
  • Accurate and timely diagnosis of COVID-19 has significant implications for patient treatment.
  • Identifying COVID-19 is critical for effective public health strategies and transmission control.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
393
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.6K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
75.4K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
509